02.09.19: Not intended for U.S. and UK Media - New guidelines from the European Society of Cardiology (ESC):

Xarelto™ 2.5 mg plus aspirin recommended for patients at high risk of heart attacks, strokes and death due to chronic coronary syndromesClinical practice guidelines from the European Society of Cardiology (ESC) recommend Xarelto vascular dose (2.5 mg twice daily) plus aspirin low dose once daily in the management of patients with chronic coronary syndromes (CCS) as well as for patients with diabetes and lower extremity arterial disease / New guidelines include a change in nomenclature from 'stable coronary artery disease' to 'chronic coronary syndromes' to better reflect the continuous high risk of heart attacks, strokes and death within this patient populationmehr ...
Source: Bayer IR Newsfeed: Events - Category: Pharmaceuticals Source Type: news